Protective effects of AS-IV on diabetic cardiomyopathy by improving myocardial lipid metabolism in rat models of T2DM
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 127, 110081
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81970630)
- Natural Science Foundation of Education Department of Anhui Province (KJ2016SD35)
This publication has 41 references indexed in Scilit:
- Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocinCardiovascular Diabetology, 2013
- Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overloadBlood, 2012
- Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic miceNutrition & Metabolism, 2009
- Autophagy regulates lipid metabolismNature, 2009
- International Diabetes Federation: a consensus on Type 2 diabetes preventionDiabetic Medicine, 2007
- Tumor Necrosis Factor-α Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload StateCirculation, 2007
- Contributions of Inflammation and Cardiac Matrix Metalloproteinase Activity to Cardiac Failure in Diabetic CardiomyopathyDiabetes, 2007
- Cardiac Metallothionein Synthesis in Streptozotocin-Induced Diabetic Mice, and Its Protection against Diabetes-Induced Cardiac InjuryThe American Journal of Pathology, 2005
- The prevention of migraine: a critical review with special emphasis on β‐adrenoceptor blockersBritish Journal of Clinical Pharmacology, 2001
- New type of cardiomyopathy associated with diabetic glomerulosclerosisThe American Journal of Cardiology, 1972